|
Market Closed -
Other stock markets
|
After hours 18:14:42 | |||
| 312.50 EUR | -1.90% |
|
314.08 | +0.50% |
| 03:46pm | UBS Adjusts Price Target on Amgen to $420 From $400, Maintains Buy Rating | MT |
| 07-08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGEN INC. | Other Pharmaceuticals | -1.90% | -1.78% | +11.49% | +23.64% | +50.28% | 196B |
-
|
-
|
-
|
- Stock Market
- Stocks
- AMGN Stock
- AMG Stock
- Charts Amgen Inc.
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
